I just wanted to send around a quick recap of the randomized control trial (RCT) that I recently completed in Zimbabwe with Medic Mobile (@isaacholeman @philip @korir @simon ) The NIH-funded study (R21) sought to use two-way texting (2wT) instead of in-person follow-up visits for male circumcision (MC) clients – testing whether it was as safe with workload and cost advantages. We now published all the findings from that study (trial protocol available here). First, we found that 2wT-based follow-up for post operative care was as safe as routine in-person follow-up for MC clients with clear workload savings for providers. We further found that 2wT was highly usable and acceptable for MC clients and providers. Lastly, we found clear cost advantages of 2wT over routine in-patient visits – costs that would incentive national scale-up and provide sizable benefits at scale.
Due to these significant benefits, the NIH recently awarded us an RO1 to implement another 2wT RCT and scale-up effort in South Africa’s MC program – this time using an implementation science approach. We will be partnering with Aurum Institute in South Africa on the 5-year study starting in July, 2020. I will post updates from those results as well.
Contact me for more details. I would be happy to talk about how we can expand and build on these experiences!